Fabrinet header image

Fabrinet

FN

Equity

ISIN KYG3323L1005 / Valor 3595304

New York Stock Exchange, Inc (2025-03-14)
USD 220.00-1.64%

Fabrinet
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Fabrinet is a leading provider of advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules, and sub-systems. With two campuses located near Bangkok, Thailand, Fabrinet leverages its well-established operations and strategic location to optimize material costs and provide scalable facilities and workforce tailored to meet customers' demands. With over 20 years of experience in volume manufacturing, Fabrinet's engineering process and assembly lines are designed for flexibility and efficiency to deliver high-quality products to its global clientele.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (21.12.2024):

Record Revenue

Fabrinet reported record revenue for the first quarter of fiscal year 2025, reaching $804.2 million. This represents a 17% increase compared to the $685.5 million recorded in the first quarter of fiscal year 2024. The revenue exceeded the company's guidance range, driven by growth across all product areas, including telecom.

GAAP Net Income

For the first quarter of fiscal year 2025, Fabrinet's GAAP net income was $77.4 million, up from $65.1 million in the same quarter of the previous year. This increase in net income reflects the company's strong revenue performance and effective cost management.

Non-GAAP Earnings

Fabrinet's non-GAAP net income for the first quarter of fiscal year 2025 was $86.9 million, compared to $72.8 million in the first quarter of fiscal year 2024. Non-GAAP net income per diluted share was $2.39, up from $2.00 in the previous year, highlighting the company's improved profitability.

Business Outlook

Looking ahead to the second quarter of fiscal year 2025, Fabrinet expects revenue to be in the range of $800 million to $820 million. The company anticipates GAAP net income per diluted share to be between $2.20 and $2.28, with non-GAAP net income per diluted share expected to range from $2.44 to $2.52.

Optimistic Future

Fabrinet's CEO, Seamus Grady, expressed optimism about the company's future, citing strong business momentum and execution. The company aims to continue expanding its market leadership and expects the positive trends to persist into the fiscal second quarter of 2025.

Summarized from source with an LLMView Source

Key figures

11.1%1Y
128%3Y
316%5Y

Performance

58.7%1Y
50.4%3Y
46.2%5Y

Volatility

Market cap

7740 M

Market cap (USD)

Daily traded volume (Shares)

1,434,778

Daily traded volume (Shares)

1 day high/low

217.07 / 213.13

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

LEGRAND SA
LEGRAND SA LEGRAND SA Valor: 2501522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.13%EUR 105.60
Worldline SA
Worldline SA Worldline SA Valor: 24715654
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.17%EUR 6.97
Rexel SA
Rexel SA Rexel SA Valor: 3015581
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.65%EUR 25.17
Ascendis Pharma
Ascendis Pharma Ascendis Pharma Valor: 26912602
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.44%USD 152.98
OVH GROUPE
OVH GROUPE OVH GROUPE Valor: 114137816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.44%EUR 7.98
Vetoquinol SA
Vetoquinol SA Vetoquinol SA Valor: 1393361
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.56%EUR 71.60
Neurones
Neurones Neurones Valor: 837153
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.29%EUR 49.15
SOLUTIONS 30 SE
SOLUTIONS 30 SE SOLUTIONS 30 SE Valor: 44600804
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.68%EUR 1.69
Novanta Inc
Novanta Inc Novanta Inc Valor: 32582414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.19%USD 136.07
ON Semiconductor Corp
ON Semiconductor Corp ON Semiconductor Corp Valor: 1117846
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.47%USD 43.19